MediPal Holdings Corporation (TYO:7459)
2,770.00
-15.00 (-0.54%)
Apr 22, 2026, 3:30 PM JST
MediPal Holdings Market Cap
MediPal Holdings has a market cap or net worth of 570.09 billion as of April 22, 2026. Its market cap has increased by 13.42% in one year.
Market Cap
570.09B
Enterprise Value
436.93B
Revenue
3.78T
Ranking
n/a
PE Ratio
13.88
Stock Price
2,770.00
Market Cap Chart
Since June 30, 1999, MediPal Holdings's market cap has increased from 47.56B to 570.09B, an increase of 1,098.66%. That is a compound annual growth rate of 9.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 570.09B | 0.54% |
| Dec 30, 2025 | 567.02B | 14.54% |
| Dec 30, 2024 | 495.03B | 2.54% |
| Dec 29, 2023 | 482.78B | 32.07% |
| Dec 30, 2022 | 365.54B | -19.21% |
| Dec 30, 2021 | 452.47B | 11.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 14.31T |
| HOYA Corporation | 9.72T |
| Takeda Pharmaceutical Company | 8.67T |
| Otsuka Holdings | 5.58T |
| Sumitomo Pharma | 792.19B |
| Sugi Holdings | 624.90B |
| Santen Pharmaceutical | 552.31B |
| COSMOS Pharmaceutical | 502.65B |